Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/17/2025

Management of Recurrent Posterior Thigh Patch in Children

Assessment and Treatment

  • The American Academy of Pediatrics recommends considering a more potent formulation or a different treatment approach for recurrent lesions that initially responded to triamcinolone but recurred, as indicated by the recurrence pattern after initial response 3
  • The location on the posterior thigh and the child's age are important considerations for treatment selection, as children have thinner skin and may be more susceptible to side effects of topical steroids 2
  • Intralesional triamcinolone hexacetonide is strongly recommended over triamcinolone acetonide for injection, as it provides more complete and longer duration of clinical response without increased adverse effects 1
  • The recommended concentration for intralesional injection is 5-10 mg/mL, with a small volume per injection site to minimize risk of atrophy 4
  • Topical calcineurin inhibitors can be considered as steroid-sparing agents, particularly if there are concerns about skin atrophy with repeated steroid use 2
  • Regular follow-up is essential to assess treatment response and monitor for potential adverse effects such as skin atrophy, telangiectasia, and pigmentary changes 2
  • If the lesion resolves, consider a maintenance regimen with twice-weekly application to prevent recurrence 2
  • If there is inadequate response to intralesional triamcinolone hexacetonide, consider dermatology referral for further evaluation and possible biopsy to confirm diagnosis 5
  • Avoid long-term continuous use of topical corticosteroids in children due to risk of skin atrophy, growth suppression, and hypothalamic-pituitary-adrenal axis suppression 6
  • Use the minimum effective amount to control symptoms and consider periodic breaks in treatment 2